药食同源中药资源产业现状及其开发利用策略与研究实践

Industry Status, Development and Utilization Strategies and Research Practices of Medicine and Food Homologous Traditional Chinese Medicine

  • 摘要: 药食同源中药是人类在长期生产和生活实践中逐渐发现的一类兼具药食两用特点的中药资源, 是健康中国建设和大健康产业发展的重要物质基础。归纳分析近年来药食同源中药资源研究现状及产业发展过程中存在问题, 通过前期研究实践探索性地提出基于药用、食用差异化发展的药食同源中药资源生产布局策略、基于现代多组学技术的药食同源中药功效表征策略、基于本草典籍记载及民间应用习惯的药食同源新品种及新部位开发策略、基于益生菌发酵技术和现代营养学理论的药食同源产品开发策略, 以期为促进药食同源中药资源的高值化开发利用提供科技支撑, 为新时代健康中国建设助力。

     

    Abstract: Medicine and food homologous traditional Chinese medicine (MFHTCM) is a type of Chinese medicinal material resource that has been gradually discovered by humans in long-term production and life practice, which combines the characteristics of both medicine and food. It is an important material foundation for the construction of a healthy China and the development of the big health industry. On the basis of summarizing and analyzing the current research status and existing problems in the industrial development process of MFHTCM in recent years, this article proposes a production layout strategy for MFHTCM based on differentiated development of medicinal and edible characteristics, a characterization strategy for MFHTCM efficacy based on modern multi-omics technology, a development strategy for new varieties and new parts of MFHTCM based on the records of Chinese herbal classics and folk application habits, and a MFHTCM development strategy of medicine and food homologous products based on probiotic fermentation technology and modern nutrition theory. All the above aim to provide technological support for promoting the high-value development and utilization of MFHTCM, and to assist in the construction of a healthy China in the new era.

     

/

返回文章
返回